Five specialty lenders andBusinessdevelopment companies reported figures for the quarter ended September 30, 2026, and the results varied widely. Hercules Capital (NYSE:HTGC) posted net investment income of $87.3 million, or $0.47 per share, with net asset value of $12.26 per share. OFS Capital (NASDAQ:OFS) …
Five insurers released third quarter 2026 results between October 28 and October 29, 2026, and their figures diverged sharply. Erie Indemnity (NASDAQ:ERIE) posted net income of $182.0 million, or $3.48 per diluted share, and policy issuance management fee revenue of $847.0 million. CNO Financial …
Five insurance companies released third quarter 2026 results between October 28 and October 30, 2026. Arthur J. Gallagher (NYSE:AJG) reported revenue before reimbursements of $3,930 million, reported EPS of $1.55 and adjusted EPS of $3.00. Ryan Specialty (NYSE:RYAN) reported total revenue of $790.0 million,Net …
Five real estateInvestmenttrusts released third quarter 2026 results, and every one reported a cashEarningsmeasure that was higher or unchanged. Cousins Properties (NYSE:CUZ), an owner of Sun Belt lifestyle office buildings, reported funds from operations of $0.75 per share, compared with $0.69 a year earlier. …
Five property owners reported third quarter 2026 results around October 29, 2026, and the picture was mixed. CubeSmart (NYSE:CUBE), a self-storage REIT, reported diluted EPS of $0.42 and FFO as adjusted of $0.66 per share. Pebblebrook Hotel Trust (NYSE:PEB), which owns urban and resort …
The ranking below relies on third quarter 2026 total revenues as stated in each company's report. All five figures are quarterly total revenues, so the basis matches, though revenue mix differs from product sales to royalties and collaboration income.
Five biotech companies reported third quarter 2026 losses and cash positions, and three of them are clinical-stage. Biohaven (NYSE:BHVN) reported a net loss of $129.3 million, or $0.86 per share, while Immuneering (NASDAQ:IMRX) reported a $24.2 million loss, or $0.37 per share. Stoke Therapeutics …
Five medical technology companies released results for the quarter ended September 30, 2026, and revenue increased at every one of them. Stryker (NYSE:SYK) recorded net sales of $6.5 billion, up 7.7%, with reported EPS of $1.96 and adjusted EPS of $3.52. Penumbra (NYSE:PEN) recorded …
Marathon Petroleum (NYSE:MPC) reports before the open. The calendar consensus of USD 26 would be about 47 percent above second quarter diluted EPS of USD 17.73, simple arithmetic, but consensus is typically on an adjusted basis and the figure is unverified. Second quarter utilization …
Five healthcare technology companies reported results for the quarter ended September 30, 2026, although Illumina's period ended September 27, 2026. Dexcom (NASDAQ:DXCM) posted revenue of $1,344.5 million, up 11%, with diluted EPS of $0.72. Illumina (NASDAQ:ILMN) posted revenue of $1.13 billion, up 4.2%, withGAAPdiluted …